Skip to main content
FinSpry Logo
FinSpry
MIRM logo
MIRM
(NASDAQ)
Mirum Pharmaceuticals, Inc.
$94.17-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Mirum Pharmaceuticals (MIRM) Stock Price & Financial Analysis

Mirum Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$92.37 - $95.14
52-Week High$109.28
52-Week Low$36.88
Open$93.64
Volume742.92K
Average Volume (3M)742.92K
Market Cap4.73B
Shares Outstanding50.20M
Price to Sales (P/S)9.11
Price to Book (P/B)15.09
EV/EBITDA277.38
Revenue (TTM)521.31M
Net Income (TTM)-23.36M
Free Cash Flow (TTM)54.87M
EPS (TTM)$-0.47
Profit Margin-4.48%
Operating Margin-4.25%
Return on Equity (ROE)-7.42%
Debt to Equity1.02
50-Day MA$96.14
200-Day MA$75.01
52-Week Change114.85%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Mirum Pharmaceuticals

What is the current stock price for MIRM?

As of the latest trading session, MIRM stock trades at $94.17. The 52-week range is $36.88–$109.28, with a day range of $92.37–$95.14.

What is the P/E ratio for MIRM?

The P/E ratio (Price-to-Earnings) for MIRM is shown in the Key Statistics section. This valuation metric helps compare Mirum Pharmaceuticals, Inc. to industry peers.

Does MIRM pay dividends?

Mirum Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for MIRM?

Based on 8 analysts, the consensus for MIRM is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of MIRM?

Mirum Pharmaceuticals's market capitalization is $4.73B, classifying it as a mid-cap company. Mirum Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.